Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer.
Nilsson RJ, Karachaliou N, Berenguer J, Gimenez-Capitan A, Schellen P, Teixido C, Tannous J, Kuiper JL, Drees E, Grabowska M, van Keulen M, Heideman DA, Thunnissen E, Dingemans AM, Viteri S, Tannous BA, Drozdowskyj A, Rosell R, Smit EF, Wurdinger T.
Nilsson RJ, et al. Among authors: thunnissen e.
Oncotarget. 2016 Jan 5;7(1):1066-75. doi: 10.18632/oncotarget.6279.
Oncotarget. 2016.
PMID: 26544515
Free PMC article.